• Теги
    • избранные теги
    • Компании311
      • Показать ещё
      Разное83
      • Показать ещё
      Страны / Регионы56
      • Показать ещё
      Международные организации3
      Формат1
      Показатели2
      Люди3
      Издания5
      Сферы1
31 января, 15:15

Allergan (AGN) Avycaz Label to Include New Phase III Data

Allergan plc (AGN) announced that its supplemental new drug application (sNDA) for antibiotic Avycaz has been approved by the FDA. Allergan is looking to include new data from two phase III trials, RECAPTURE and REPRISE, in the drug???s label.

Выбор редакции
30 января, 15:35

Ironwood/Astellas Report Positive Phase III Data on Linzess

Ironwood (IRWD) and partner Astellas reported positive top-line data from a phase III study on Linzess in adults with chronic constipation.

30 января, 15:34

Amgen Wins Favorable CHMP Opinion for Humira Biosimilar

Amgen (AMGN) announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has rendered a positive opinion on the company's marketing authorization application (MAA) for ABP 501.

Выбор редакции
Выбор редакции
27 января, 17:19

Ironwood-Allergan Linzess Gets FDA Approval in Lower Dose

Ironwood Pharmaceuticals, Inc. (IRWD) and partner Allergan plc (AGN) announced that the FDA has approved a lower dose strength of Linzess (linaclotide) ??? 72 mcg ??? for the treatment of adult patients with chronic idiopathic constipation (CIC).

24 января, 17:55

Theravance's Infection Drug Vibativ Positive in TOUR Study

Theravance Biopharma, Inc. (TBPH) recently released positive interim data from the ongoing TOURstudy evaluating how Vibativ (telavancin) is used to treat patients with bacteremia or infective endocarditis (IE).

24 января, 15:35

5 главных целей для поглощения в биотехе

Биотехнологии – это один из секторов, которые очень сильно зависят от перемен настроений в политике, в особенности там, где речь идет о ценах на медикаменты.

24 января, 15:35

5 главных целей для поглощения в биотехе

Биотехнологии – это один из секторов, которые очень сильно зависят от перемен настроений в политике, в особенности там, где речь идет о ценах на медикаменты.

23 января, 11:15

Allergan заплатит $15 млн за нераскрытие существенной информации

Комиссия по ценным бумагам и биржам США (SEC) решила оштрафовать фармацевтическую компанию Allergan Plc за нераскрытие существенной информации, касающейся переговоров о слиянии.

20 января, 22:52

Novartis (NVS) Q4 Earnings: Stock Likely to Disappoint?

Swiss pharmaceutical company Novartis AG (NVS) is scheduled to report fourth-quarter and full year 2016 results on Jan 25.

Выбор редакции
20 января, 16:17

Allergan (AGN) Rhofade Cream for Rosacea Approved in U.S.

Allergan plc (AGN) announced that the FDA has approved Rhofade (oxymetazoline hydrochloride) cream for topical treatment of persistent facial erythema (redness) associated with rosacea in adults.

19 января, 17:30

Should Value Investors Choose Allergan (AGN)?

Allergan (AGN) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.

19 января, 17:04

Apricus (APRI) Stock Gains on Vitaros' Approval in Mexico

Apricus (APRI) announced that Vitaros was approved in Mexico for the treatment of patients with erectile dysfunction.

19 января, 16:40

Biogen (BIIB) Q4 Earnings: What's in Store for the Stock?

Biogen Inc. (BIIB), a well-known name in the multiple sclerosis (MS) market, will be reporting fourth-quarter 2016 and full-year earnings on Jan 26.

19 января, 16:37

Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat?

We expect biotech company Vertex Pharmaceuticals, Inc. (VRTX) to beat expectations when it reports fourth-quarter 2016 and full-year earnings results on Jan 25, after the market closes.

Выбор редакции
19 января, 16:01

Allergan says its cream for facial redness was approved by the FDA

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

19 января, 00:22

Allergan's Uterine Fibroids Candidate Positive in Phase III

Allergan Plc (AGN) and European specialty pharma company Gedeon Richter reported encouraging results from a phase III study on their pipeline candidate, ulipristal acetate, in women with abnormal bleeding due to uterine fibroids.

Выбор редакции